JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 21 No. 2 147-152
© 1980 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kung, H. F.
Right arrow Articles by Blau, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kung, H. F.
Right arrow Articles by Blau, M.

Regional Intracellular pH Shift: A Proposed New Mechanism for Radiopharmaceutical Uptake in Brain and Other Tissues

Hank F. Kung and Monte Blau

State University of New York at Buffalo, Buffalo, New York

Correspondence: For reprints contact: Hank F. Kung, Dept. of Nuclear Medicine, VA Medical Center, 3495 Bailey Ave., Buffalo, NY 14215.

ABSTRACT

This paper proposes a new mechanism for radiopharmaceutical uptake, which may be applicable to a variety of clinical studies. Many tissues and organs have low intracellular pH, either normally or as a result of various metabolic disturbances. We have developed a series of compounds that are neutral and lipid-soluble at blood pH. These molecules can diffuse freely into cells. In those regions where intracellular pH is low, they pick up a hydrogen ion and become charged. In this form they are no longer lipid-soluble and are trapped because they cannot diffuse out of the cell. Studies of the brain uptake of two compounds of this type, Se-75 labeled di-ß-(morpholinoethyl)-selenide (MOSE) and di-ß-(piperidinoethyl)-selenide (PIPSE), demonstrate the application of the principle.




This article has been cited by other articles:


Home page
Vasc MedHome page
D. C. Costa
Single photon emission tomography (SPET) with 99Tc m-hexamethylpropyleneamineoxime (HMPAO) in research and clinical practice - a useful tool
Vascular Medicine, September 1, 1990; 1(2): 179 - 201.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1980 by the Society of Nuclear Medicine.